The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A matching-adjusted indirect treatment comparison of elranatamab in patients with triple-class exposed relapsed/refractory multiple myeloma: Comparisons with belantamab mafodotin, selinexor plus dexamethasone, and real-world physician’s choice of treatment.
 
Patrick Hlavacek
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Isha Mol
No Relationships to Disclose
 
Yannan Hu
No Relationships to Disclose
 
Joseph C. Cappelleri
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Haitao Chu
Employment - Pfizer
Stock and Other Ownership Interests - Medtronic (I)
 
Didem Aydin
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer